Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
88 |
1381 |
4.847e-40 |
2.255e-36 |
2 |
RESPONSE TO ENDOGENOUS STIMULUS |
85 |
1450 |
8.826e-36 |
2.053e-32 |
3 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
92 |
1848 |
2.06e-33 |
3.195e-30 |
4 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
69 |
1008 |
1.225e-32 |
1.425e-29 |
5 |
RESPONSE TO NITROGEN COMPOUND |
63 |
859 |
2.328e-31 |
2.167e-28 |
6 |
RESPONSE TO HORMONE |
63 |
893 |
2.131e-30 |
1.652e-27 |
7 |
HOMEOSTATIC PROCESS |
74 |
1337 |
3.878e-29 |
2.578e-26 |
8 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
58 |
799 |
1.515e-28 |
8.81e-26 |
9 |
ANION TRANSPORT |
47 |
507 |
1.189e-27 |
6.149e-25 |
10 |
CHEMICAL HOMEOSTASIS |
59 |
874 |
2.204e-27 |
1.026e-24 |
11 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
60 |
917 |
3.855e-27 |
1.631e-24 |
12 |
RESPONSE TO OXIDATIVE STRESS |
40 |
352 |
6.237e-27 |
2.418e-24 |
13 |
ION TRANSPORT |
68 |
1262 |
6.118e-26 |
2.19e-23 |
14 |
RESPONSE TO PEPTIDE |
41 |
404 |
1.159e-25 |
3.852e-23 |
15 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
46 |
552 |
4.416e-25 |
1.37e-22 |
16 |
RESPONSE TO OXYGEN LEVELS |
36 |
311 |
1.448e-24 |
4.211e-22 |
17 |
RESPONSE TO LIPID |
56 |
888 |
1.725e-24 |
4.72e-22 |
18 |
ORGANIC ANION TRANSPORT |
39 |
387 |
2.573e-24 |
6.652e-22 |
19 |
NEGATIVE REGULATION OF CELL DEATH |
55 |
872 |
4.787e-24 |
1.172e-21 |
20 |
RESPONSE TO ABIOTIC STIMULUS |
59 |
1024 |
7.922e-24 |
1.843e-21 |
21 |
RESPONSE TO INORGANIC SUBSTANCE |
42 |
479 |
8.961e-24 |
1.986e-21 |
22 |
TRANSMEMBRANE TRANSPORT |
59 |
1098 |
2.652e-22 |
5.609e-20 |
23 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
41 |
505 |
5.929e-22 |
1.199e-19 |
24 |
ORGANIC ACID TRANSPORT |
31 |
261 |
1.369e-21 |
2.655e-19 |
25 |
REGULATION OF CELL DEATH |
67 |
1472 |
1.904e-21 |
3.544e-19 |
26 |
RESPONSE TO INSULIN |
28 |
205 |
2.945e-21 |
5.271e-19 |
27 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
27 |
191 |
6.203e-21 |
1.069e-18 |
28 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
58 |
1142 |
1.007e-20 |
1.673e-18 |
29 |
RESPONSE TO DRUG |
37 |
431 |
1.103e-20 |
1.77e-18 |
30 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
69 |
1618 |
1.498e-20 |
2.323e-18 |
31 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
55 |
1036 |
1.632e-20 |
2.373e-18 |
32 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
55 |
1036 |
1.632e-20 |
2.373e-18 |
33 |
POSITIVE REGULATION OF CELL COMMUNICATION |
65 |
1532 |
3.494e-19 |
4.927e-17 |
34 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
25 |
184 |
4.973e-19 |
6.805e-17 |
35 |
RESPONSE TO STEROID HORMONE |
37 |
497 |
1.337e-18 |
1.777e-16 |
36 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
24 |
172 |
1.379e-18 |
1.782e-16 |
37 |
SMALL MOLECULE METABOLIC PROCESS |
69 |
1767 |
1.779e-18 |
2.237e-16 |
38 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
20 |
106 |
2.379e-18 |
2.913e-16 |
39 |
LIPID METABOLIC PROCESS |
55 |
1158 |
2.578e-18 |
3.076e-16 |
40 |
CELLULAR HOMEOSTASIS |
42 |
676 |
3.913e-18 |
4.552e-16 |
41 |
CELLULAR RESPONSE TO PEPTIDE |
28 |
274 |
7.847e-18 |
8.906e-16 |
42 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
59 |
1395 |
2.727e-17 |
3.022e-15 |
43 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
41 |
689 |
4.719e-17 |
5.106e-15 |
44 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
46 |
876 |
5.626e-17 |
5.949e-15 |
45 |
REGULATION OF MAPK CASCADE |
40 |
660 |
6.372e-17 |
6.588e-15 |
46 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
34 |
465 |
6.519e-17 |
6.594e-15 |
47 |
RESPONSE TO EXTERNAL STIMULUS |
67 |
1821 |
1.368e-16 |
1.354e-14 |
48 |
REGULATION OF CELL DIFFERENTIATION |
60 |
1492 |
1.449e-16 |
1.405e-14 |
49 |
ION HOMEOSTASIS |
37 |
576 |
1.658e-16 |
1.575e-14 |
50 |
NEGATIVE REGULATION OF NEURON DEATH |
22 |
171 |
2.308e-16 |
2.147e-14 |
51 |
ORGANIC ACID METABOLIC PROCESS |
47 |
953 |
2.769e-16 |
2.526e-14 |
52 |
POSITIVE REGULATION OF CELL PROLIFERATION |
43 |
814 |
5.498e-16 |
4.92e-14 |
53 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
59 |
1492 |
5.954e-16 |
5.227e-14 |
54 |
REGULATION OF CELL PROLIFERATION |
59 |
1496 |
6.722e-16 |
5.792e-14 |
55 |
RESPONSE TO EXTRACELLULAR STIMULUS |
32 |
441 |
7.157e-16 |
6.055e-14 |
56 |
ANION TRANSMEMBRANE TRANSPORT |
25 |
251 |
9.088e-16 |
7.551e-14 |
57 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
20 |
143 |
1.066e-15 |
8.701e-14 |
58 |
RESPONSE TO METAL ION |
28 |
333 |
1.27e-15 |
1.019e-13 |
59 |
CELLULAR LIPID METABOLIC PROCESS |
45 |
913 |
1.352e-15 |
1.066e-13 |
60 |
RESPONSE TO HYDROGEN PEROXIDE |
18 |
109 |
1.473e-15 |
1.142e-13 |
61 |
REGULATION OF LIPID METABOLIC PROCESS |
26 |
282 |
1.538e-15 |
1.173e-13 |
62 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
50 |
1135 |
2.441e-15 |
1.832e-13 |
63 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
64 |
1791 |
3.273e-15 |
2.417e-13 |
64 |
CELLULAR CHEMICAL HOMEOSTASIS |
35 |
570 |
4.615e-15 |
3.355e-13 |
65 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
41 |
788 |
4.823e-15 |
3.4e-13 |
66 |
CIRCULATORY SYSTEM DEVELOPMENT |
41 |
788 |
4.823e-15 |
3.4e-13 |
67 |
HEXOSE METABOLIC PROCESS |
20 |
157 |
6.746e-15 |
4.685e-13 |
68 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
19 |
138 |
7.615e-15 |
5.152e-13 |
69 |
RESPONSE TO PURINE CONTAINING COMPOUND |
20 |
158 |
7.64e-15 |
5.152e-13 |
70 |
MONOSACCHARIDE METABOLIC PROCESS |
22 |
202 |
8.058e-15 |
5.356e-13 |
71 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
66 |
1929 |
8.69e-15 |
5.695e-13 |
72 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
16 |
87 |
9.769e-15 |
6.314e-13 |
73 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
44 |
926 |
1.083e-14 |
6.905e-13 |
74 |
REGULATION OF KINASE ACTIVITY |
40 |
776 |
1.477e-14 |
9.289e-13 |
75 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
61 |
1710 |
1.907e-14 |
1.183e-12 |
76 |
CELLULAR RESPONSE TO STRESS |
58 |
1565 |
1.936e-14 |
1.185e-12 |
77 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
32 |
498 |
2.18e-14 |
1.317e-12 |
78 |
LIPID LOCALIZATION |
24 |
264 |
2.724e-14 |
1.625e-12 |
79 |
REGULATION OF RESPONSE TO WOUNDING |
29 |
413 |
4.186e-14 |
2.466e-12 |
80 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
19 |
152 |
4.643e-14 |
2.7e-12 |
81 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
59 |
1656 |
6.092e-14 |
3.499e-12 |
82 |
ORGANIC HYDROXY COMPOUND TRANSPORT |
19 |
155 |
6.67e-14 |
3.785e-12 |
83 |
OXIDATION REDUCTION PROCESS |
42 |
898 |
8.137e-14 |
4.562e-12 |
84 |
GLUCOSE METABOLIC PROCESS |
17 |
119 |
1.108e-13 |
6.136e-12 |
85 |
POSITIVE REGULATION OF MAPK CASCADE |
30 |
470 |
1.797e-13 |
9.832e-12 |
86 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
16 |
104 |
1.817e-13 |
9.832e-12 |
87 |
MONOCARBOXYLIC ACID TRANSPORT |
17 |
124 |
2.221e-13 |
1.188e-11 |
88 |
RESPONSE TO GROWTH FACTOR |
30 |
475 |
2.363e-13 |
1.249e-11 |
89 |
TISSUE DEVELOPMENT |
55 |
1518 |
2.731e-13 |
1.428e-11 |
90 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
18 |
146 |
2.804e-13 |
1.45e-11 |
91 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
58 |
1672 |
3.27e-13 |
1.672e-11 |
92 |
POSITIVE REGULATION OF KINASE ACTIVITY |
30 |
482 |
3.447e-13 |
1.743e-11 |
93 |
GLYCEROLIPID METABOLIC PROCESS |
26 |
356 |
3.808e-13 |
1.885e-11 |
94 |
CARBOHYDRATE METABOLIC PROCESS |
35 |
662 |
3.8e-13 |
1.885e-11 |
95 |
REGULATION OF TRANSFERASE ACTIVITY |
42 |
946 |
4.611e-13 |
2.259e-11 |
96 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
39 |
823 |
4.718e-13 |
2.287e-11 |
97 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
13 |
62 |
5.506e-13 |
2.641e-11 |
98 |
BLOOD VESSEL MORPHOGENESIS |
26 |
364 |
6.355e-13 |
3.017e-11 |
99 |
REGULATION OF NEURON DEATH |
22 |
252 |
7.73e-13 |
3.633e-11 |
100 |
MONOCARBOXYLIC ACID METABOLIC PROCESS |
30 |
503 |
1.028e-12 |
4.767e-11 |
101 |
VASCULATURE DEVELOPMENT |
29 |
469 |
1.035e-12 |
4.767e-11 |
102 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
63 |
1977 |
1.052e-12 |
4.8e-11 |
103 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
33 |
616 |
1.335e-12 |
6.029e-11 |
104 |
RESPONSE TO ORGANOPHOSPHORUS |
17 |
139 |
1.495e-12 |
6.687e-11 |
105 |
LIPID MODIFICATION |
20 |
210 |
1.767e-12 |
7.831e-11 |
106 |
REGULATION OF LIPID STORAGE |
11 |
41 |
1.859e-12 |
8.161e-11 |
107 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
22 |
264 |
1.973e-12 |
8.579e-11 |
108 |
ANGIOGENESIS |
23 |
293 |
2.107e-12 |
9.079e-11 |
109 |
REGULATION OF TRANSPORT |
59 |
1804 |
2.332e-12 |
9.955e-11 |
110 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
59 |
1805 |
2.386e-12 |
1.009e-10 |
111 |
SINGLE ORGANISM CATABOLIC PROCESS |
41 |
957 |
2.855e-12 |
1.197e-10 |
112 |
PHOSPHORYLATION |
47 |
1228 |
3.14e-12 |
1.304e-10 |
113 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
14 |
87 |
3.226e-12 |
1.328e-10 |
114 |
CELLULAR RESPONSE TO LIPID |
28 |
457 |
3.26e-12 |
1.331e-10 |
115 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
53 |
1518 |
3.441e-12 |
1.392e-10 |
116 |
RESPONSE TO ALCOHOL |
25 |
362 |
3.806e-12 |
1.527e-10 |
117 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
36 |
771 |
6.351e-12 |
2.509e-10 |
118 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
28 |
470 |
6.364e-12 |
2.509e-10 |
119 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
13 |
75 |
7.279e-12 |
2.846e-10 |
120 |
ION TRANSMEMBRANE TRANSPORT |
37 |
822 |
9.126e-12 |
3.539e-10 |
121 |
REGULATION OF HORMONE LEVELS |
28 |
478 |
9.495e-12 |
3.651e-10 |
122 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
17 |
156 |
9.901e-12 |
3.776e-10 |
123 |
RESPONSE TO ACID CHEMICAL |
23 |
319 |
1.208e-11 |
4.571e-10 |
124 |
RESPONSE TO MECHANICAL STIMULUS |
19 |
210 |
1.599e-11 |
5.999e-10 |
125 |
PEPTIDYL TYROSINE MODIFICATION |
18 |
186 |
1.804e-11 |
6.713e-10 |
126 |
SINGLE ORGANISM BIOSYNTHETIC PROCESS |
48 |
1340 |
1.841e-11 |
6.799e-10 |
127 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
12 |
65 |
2.176e-11 |
7.971e-10 |
128 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
14 |
100 |
2.286e-11 |
8.31e-10 |
129 |
POSITIVE REGULATION OF TRANSPORT |
39 |
936 |
2.414e-11 |
8.707e-10 |
130 |
RESPONSE TO ESTROGEN |
19 |
218 |
3.077e-11 |
1.101e-09 |
131 |
ORGANIC ACID TRANSMEMBRANE TRANSPORT |
14 |
103 |
3.445e-11 |
1.224e-09 |
132 |
NITROGEN COMPOUND TRANSPORT |
28 |
507 |
3.785e-11 |
1.314e-09 |
133 |
REGULATION OF SYSTEM PROCESS |
28 |
507 |
3.785e-11 |
1.314e-09 |
134 |
INOSITOL LIPID MEDIATED SIGNALING |
15 |
124 |
3.739e-11 |
1.314e-09 |
135 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
11 |
53 |
3.937e-11 |
1.337e-09 |
136 |
RESPONSE TO CAMP |
14 |
104 |
3.937e-11 |
1.337e-09 |
137 |
REGULATION OF RESPONSE TO STRESS |
50 |
1468 |
3.929e-11 |
1.337e-09 |
138 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
13 |
86 |
4.438e-11 |
1.496e-09 |
139 |
CATION TRANSPORT |
35 |
796 |
6.746e-11 |
2.258e-09 |
140 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
22 |
321 |
9.205e-11 |
3.059e-09 |
141 |
GENERATION OF PRECURSOR METABOLITES AND ENERGY |
21 |
292 |
1.03e-10 |
3.398e-09 |
142 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
25 |
422 |
1.038e-10 |
3.4e-09 |
143 |
IMMUNE SYSTEM PROCESS |
59 |
1984 |
1.118e-10 |
3.638e-09 |
144 |
PROTEIN PHOSPHORYLATION |
38 |
944 |
1.221e-10 |
3.944e-09 |
145 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
15 |
135 |
1.278e-10 |
4.101e-09 |
146 |
UROGENITAL SYSTEM DEVELOPMENT |
21 |
299 |
1.597e-10 |
5.089e-09 |
147 |
REGULATION OF LIPID TRANSPORT |
13 |
95 |
1.613e-10 |
5.105e-09 |
148 |
RESPONSE TO TOXIC SUBSTANCE |
19 |
241 |
1.741e-10 |
5.474e-09 |
149 |
MONOVALENT INORGANIC CATION TRANSPORT |
25 |
435 |
1.966e-10 |
6.14e-09 |
150 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
18 |
218 |
2.516e-10 |
7.805e-09 |
151 |
SMALL MOLECULE BIOSYNTHETIC PROCESS |
25 |
443 |
2.88e-10 |
8.874e-09 |
152 |
PEPTIDYL AMINO ACID MODIFICATION |
35 |
841 |
2.977e-10 |
9.113e-09 |
153 |
REGULATION OF MEMBRANE POTENTIAL |
22 |
343 |
3.266e-10 |
9.933e-09 |
154 |
GLUCOSE HOMEOSTASIS |
16 |
170 |
3.732e-10 |
1.12e-08 |
155 |
CARBOHYDRATE HOMEOSTASIS |
16 |
170 |
3.732e-10 |
1.12e-08 |
156 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
9 |
36 |
4.067e-10 |
1.213e-08 |
157 |
REGULATION OF COENZYME METABOLIC PROCESS |
10 |
50 |
4.582e-10 |
1.349e-08 |
158 |
REGULATION OF COFACTOR METABOLIC PROCESS |
10 |
50 |
4.582e-10 |
1.349e-08 |
159 |
EPITHELIUM DEVELOPMENT |
37 |
945 |
4.778e-10 |
1.398e-08 |
160 |
REGULATION OF CELLULAR KETONE METABOLIC PROCESS |
16 |
173 |
4.841e-10 |
1.408e-08 |
161 |
REGULATION OF CATABOLIC PROCESS |
32 |
731 |
5.373e-10 |
1.553e-08 |
162 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
14 |
128 |
6.624e-10 |
1.903e-08 |
163 |
NEGATIVE REGULATION OF LIPID STORAGE |
7 |
17 |
7.046e-10 |
2.011e-08 |
164 |
REGULATION OF INFLAMMATORY RESPONSE |
20 |
294 |
7.758e-10 |
2.201e-08 |
165 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
27 |
541 |
8.15e-10 |
2.285e-08 |
166 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
27 |
541 |
8.15e-10 |
2.285e-08 |
167 |
REGULATION OF BODY FLUID LEVELS |
26 |
506 |
9.265e-10 |
2.581e-08 |
168 |
REGULATION OF IMMUNE SYSTEM PROCESS |
46 |
1403 |
9.513e-10 |
2.635e-08 |
169 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
12 |
89 |
9.871e-10 |
2.718e-08 |
170 |
RESPONSE TO KETONE |
16 |
182 |
1.024e-09 |
2.803e-08 |
171 |
REGULATION OF ERK1 AND ERK2 CASCADE |
18 |
238 |
1.044e-09 |
2.842e-08 |
172 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
14 |
133 |
1.104e-09 |
2.986e-08 |
173 |
SECRETION |
28 |
588 |
1.111e-09 |
2.988e-08 |
174 |
ORGANOPHOSPHATE METABOLIC PROCESS |
35 |
885 |
1.148e-09 |
3.07e-08 |
175 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
8 |
28 |
1.213e-09 |
3.226e-08 |
176 |
POSITIVE REGULATION OF GENE EXPRESSION |
52 |
1733 |
1.392e-09 |
3.68e-08 |
177 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
16 |
188 |
1.648e-09 |
4.332e-08 |
178 |
REGULATION OF NEURON APOPTOTIC PROCESS |
16 |
192 |
2.24e-09 |
5.824e-08 |
179 |
PROTEIN AUTOPHOSPHORYLATION |
16 |
192 |
2.24e-09 |
5.824e-08 |
180 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
36 |
957 |
2.455e-09 |
6.345e-08 |
181 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
37 |
1004 |
2.495e-09 |
6.413e-08 |
182 |
SINGLE ORGANISM BEHAVIOR |
22 |
384 |
2.698e-09 |
6.897e-08 |
183 |
POSITIVE REGULATION OF LOCOMOTION |
23 |
420 |
2.742e-09 |
6.971e-08 |
184 |
CARBOHYDRATE BIOSYNTHETIC PROCESS |
13 |
121 |
3.414e-09 |
8.587e-08 |
185 |
REGULATION OF PROTEIN KINASE B SIGNALING |
13 |
121 |
3.414e-09 |
8.587e-08 |
186 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
19 |
289 |
3.674e-09 |
9.192e-08 |
187 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
52 |
1784 |
3.781e-09 |
9.409e-08 |
188 |
IMMUNE SYSTEM DEVELOPMENT |
27 |
582 |
3.935e-09 |
9.654e-08 |
189 |
INTRACELLULAR SIGNAL TRANSDUCTION |
48 |
1572 |
3.942e-09 |
9.654e-08 |
190 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
37 |
1021 |
3.915e-09 |
9.654e-08 |
191 |
MONOVALENT INORGANIC CATION HOMEOSTASIS |
13 |
123 |
4.181e-09 |
1.019e-07 |
192 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
14 |
148 |
4.504e-09 |
1.091e-07 |
193 |
CELL DEVELOPMENT |
45 |
1426 |
4.901e-09 |
1.182e-07 |
194 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
32 |
801 |
5.011e-09 |
1.202e-07 |
195 |
SMALL MOLECULE CATABOLIC PROCESS |
20 |
328 |
5.118e-09 |
1.221e-07 |
196 |
RESPONSE TO CORTICOSTEROID |
15 |
176 |
5.29e-09 |
1.234e-07 |
197 |
REGULATION OF DEFENSE RESPONSE |
31 |
759 |
5.321e-09 |
1.234e-07 |
198 |
REGULATION OF CELLULAR LOCALIZATION |
42 |
1277 |
5.307e-09 |
1.234e-07 |
199 |
NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
6 |
13 |
5.33e-09 |
1.234e-07 |
200 |
REGULATION OF CHOLESTEROL STORAGE |
6 |
13 |
5.33e-09 |
1.234e-07 |
201 |
REGULATION OF VASCULATURE DEVELOPMENT |
17 |
233 |
5.303e-09 |
1.234e-07 |
202 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
9 |
48 |
6.369e-09 |
1.467e-07 |
203 |
RESPONSE TO STARVATION |
14 |
154 |
7.547e-09 |
1.73e-07 |
204 |
NEUTRAL LIPID METABOLIC PROCESS |
11 |
85 |
7.785e-09 |
1.776e-07 |
205 |
RESPONSE TO WOUNDING |
26 |
563 |
8.552e-09 |
1.941e-07 |
206 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
18 |
272 |
8.661e-09 |
1.956e-07 |
207 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
6 |
14 |
9.231e-09 |
2.055e-07 |
208 |
SECRETION BY CELL |
24 |
486 |
9.213e-09 |
2.055e-07 |
209 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
33 |
867 |
9.215e-09 |
2.055e-07 |
210 |
HORMONE MEDIATED SIGNALING PATHWAY |
14 |
158 |
1.051e-08 |
2.329e-07 |
211 |
LIPID HOMEOSTASIS |
12 |
110 |
1.164e-08 |
2.554e-07 |
212 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
12 |
110 |
1.164e-08 |
2.554e-07 |
213 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
27 |
616 |
1.303e-08 |
2.847e-07 |
214 |
NEGATIVE REGULATION OF TRANSPORT |
23 |
458 |
1.398e-08 |
3.04e-07 |
215 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
14 |
162 |
1.449e-08 |
3.137e-07 |
216 |
RESPONSE TO ALKALOID |
13 |
137 |
1.562e-08 |
3.364e-07 |
217 |
RESPONSE TO NUTRIENT |
15 |
191 |
1.609e-08 |
3.449e-07 |
218 |
REGULATION OF STEROL TRANSPORT |
8 |
38 |
1.716e-08 |
3.63e-07 |
219 |
REGULATION OF CHOLESTEROL TRANSPORT |
8 |
38 |
1.716e-08 |
3.63e-07 |
220 |
REGULATION OF GLUCONEOGENESIS |
8 |
38 |
1.716e-08 |
3.63e-07 |
221 |
DEVELOPMENTAL MATURATION |
15 |
193 |
1.851e-08 |
3.897e-07 |
222 |
RESPONSE TO CYTOKINE |
29 |
714 |
1.955e-08 |
4.098e-07 |
223 |
REGULATED EXOCYTOSIS |
16 |
224 |
2.042e-08 |
4.262e-07 |
224 |
POSITIVE REGULATION OF STAT CASCADE |
10 |
73 |
2.162e-08 |
4.47e-07 |
225 |
POSITIVE REGULATION OF JAK STAT CASCADE |
10 |
73 |
2.162e-08 |
4.47e-07 |
226 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
39 |
1192 |
2.342e-08 |
4.822e-07 |
227 |
TUBE DEVELOPMENT |
25 |
552 |
2.468e-08 |
5.059e-07 |
228 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
8 |
40 |
2.642e-08 |
5.368e-07 |
229 |
FATTY ACID TRANSPORT |
9 |
56 |
2.64e-08 |
5.368e-07 |
230 |
CELL DEATH |
35 |
1001 |
2.664e-08 |
5.389e-07 |
231 |
PHOSPHOLIPID METABOLIC PROCESS |
20 |
364 |
2.941e-08 |
5.923e-07 |
232 |
FATTY ACID METABOLIC PROCESS |
18 |
296 |
3.2e-08 |
6.417e-07 |
233 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
42 |
1360 |
3.223e-08 |
6.436e-07 |
234 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
18 |
297 |
3.369e-08 |
6.699e-07 |
235 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
23 |
482 |
3.582e-08 |
7.093e-07 |
236 |
POSITIVE REGULATION OF CELL DEATH |
26 |
605 |
3.663e-08 |
7.221e-07 |
237 |
REGULATION OF FATTY ACID OXIDATION |
7 |
28 |
3.82e-08 |
7.5e-07 |
238 |
CELLULAR RESPONSE TO ACID CHEMICAL |
14 |
175 |
3.872e-08 |
7.57e-07 |
239 |
LIPID PHOSPHORYLATION |
11 |
99 |
3.951e-08 |
7.692e-07 |
240 |
MODULATION OF SYNAPTIC TRANSMISSION |
18 |
301 |
4.132e-08 |
8.011e-07 |
241 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
26 |
609 |
4.177e-08 |
8.065e-07 |
242 |
CELL ACTIVATION |
25 |
568 |
4.301e-08 |
8.271e-07 |
243 |
RESPONSE TO BACTERIUM |
24 |
528 |
4.462e-08 |
8.544e-07 |
244 |
REGULATION OF SECRETION |
28 |
699 |
4.685e-08 |
8.935e-07 |
245 |
REGULATION OF OSSIFICATION |
14 |
178 |
4.798e-08 |
9.113e-07 |
246 |
REGULATION OF GLUCOSE IMPORT |
9 |
60 |
4.935e-08 |
9.335e-07 |
247 |
REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
9 |
61 |
5.728e-08 |
1.075e-06 |
248 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
9 |
61 |
5.728e-08 |
1.075e-06 |
249 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
19 |
343 |
5.809e-08 |
1.085e-06 |
250 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
15 |
213 |
6.887e-08 |
1.282e-06 |
251 |
SYSTEM PROCESS |
49 |
1785 |
7.808e-08 |
1.447e-06 |
252 |
DRUG TRANSMEMBRANE TRANSPORT |
6 |
19 |
7.919e-08 |
1.462e-06 |
253 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
37 |
1152 |
9.017e-08 |
1.658e-06 |
254 |
COGNITION |
16 |
251 |
9.972e-08 |
1.827e-06 |
255 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
7 |
32 |
1.041e-07 |
1.9e-06 |
256 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
20 |
395 |
1.12e-07 |
2.029e-06 |
257 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
6 |
20 |
1.12e-07 |
2.029e-06 |
258 |
REGULATION OF LIPID KINASE ACTIVITY |
8 |
48 |
1.19e-07 |
2.147e-06 |
259 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
7 |
33 |
1.308e-07 |
2.349e-06 |
260 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
14 |
193 |
1.318e-07 |
2.352e-06 |
261 |
AMINO ACID TRANSMEMBRANE TRANSPORT |
9 |
67 |
1.324e-07 |
2.352e-06 |
262 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS |
9 |
67 |
1.324e-07 |
2.352e-06 |
263 |
REGULATION OF HYDROLASE ACTIVITY |
40 |
1327 |
1.376e-07 |
2.435e-06 |
264 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
8 |
49 |
1.408e-07 |
2.472e-06 |
265 |
REGULATION OF ATP METABOLIC PROCESS |
8 |
49 |
1.408e-07 |
2.472e-06 |
266 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
9 |
68 |
1.51e-07 |
2.641e-06 |
267 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
28 |
740 |
1.526e-07 |
2.659e-06 |
268 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
20 |
404 |
1.611e-07 |
2.797e-06 |
269 |
RESPONSE TO FLUID SHEAR STRESS |
7 |
34 |
1.629e-07 |
2.818e-06 |
270 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
33 |
983 |
1.786e-07 |
3.078e-06 |
271 |
REGULATION OF HORMONE SECRETION |
16 |
262 |
1.793e-07 |
3.079e-06 |
272 |
REGULATION OF BLOOD PRESSURE |
13 |
169 |
1.891e-07 |
3.235e-06 |
273 |
AGING |
16 |
264 |
1.988e-07 |
3.389e-06 |
274 |
CELLULAR RESPONSE TO STARVATION |
11 |
117 |
2.237e-07 |
3.8e-06 |
275 |
CELLULAR CARBOHYDRATE METABOLIC PROCESS |
12 |
144 |
2.368e-07 |
3.992e-06 |
276 |
SODIUM ION TRANSPORT |
12 |
144 |
2.368e-07 |
3.992e-06 |
277 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
7 |
36 |
2.476e-07 |
4.159e-06 |
278 |
RESPONSE TO ESTRADIOL |
12 |
146 |
2.752e-07 |
4.607e-06 |
279 |
RESPONSE TO INCREASED OXYGEN LEVELS |
6 |
23 |
2.827e-07 |
4.697e-06 |
280 |
RESPONSE TO HYPEROXIA |
6 |
23 |
2.827e-07 |
4.697e-06 |
281 |
IMPORT INTO CELL |
7 |
37 |
3.021e-07 |
5.003e-06 |
282 |
REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
10 |
96 |
3.061e-07 |
5.051e-06 |
283 |
MONOSACCHARIDE BIOSYNTHETIC PROCESS |
8 |
54 |
3.079e-07 |
5.063e-06 |
284 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
16 |
274 |
3.287e-07 |
5.386e-06 |
285 |
REGULATION OF ION TRANSPORT |
24 |
592 |
3.661e-07 |
5.978e-06 |
286 |
POSITIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
6 |
24 |
3.73e-07 |
6.026e-06 |
287 |
POSITIVE REGULATION OF ATP METABOLIC PROCESS |
6 |
24 |
3.73e-07 |
6.026e-06 |
288 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
10 |
98 |
3.72e-07 |
6.026e-06 |
289 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
14 |
211 |
3.936e-07 |
6.337e-06 |
290 |
AMINO ACID TRANSPORT |
11 |
124 |
4.042e-07 |
6.486e-06 |
291 |
WOUND HEALING |
21 |
470 |
4.278e-07 |
6.841e-06 |
292 |
KIDNEY EPITHELIUM DEVELOPMENT |
11 |
125 |
4.385e-07 |
6.987e-06 |
293 |
AMMONIUM TRANSPORT |
8 |
57 |
4.737e-07 |
7.522e-06 |
294 |
DRUG TRANSPORT |
6 |
25 |
4.858e-07 |
7.688e-06 |
295 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
12 |
154 |
4.906e-07 |
7.738e-06 |
296 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
34 |
1079 |
4.961e-07 |
7.784e-06 |
297 |
BEHAVIOR |
22 |
516 |
4.968e-07 |
7.784e-06 |
298 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
5 |
14 |
5.044e-07 |
7.875e-06 |
299 |
REGULATION OF MAP KINASE ACTIVITY |
17 |
319 |
5.084e-07 |
7.911e-06 |
300 |
RENAL SYSTEM PROCESS |
10 |
102 |
5.419e-07 |
8.404e-06 |
301 |
ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS |
14 |
217 |
5.527e-07 |
8.544e-06 |
302 |
RESPONSE TO BIOTIC STIMULUS |
30 |
886 |
5.709e-07 |
8.797e-06 |
303 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
10 |
103 |
5.937e-07 |
9.117e-06 |
304 |
STEROL HOMEOSTASIS |
8 |
59 |
6.223e-07 |
9.463e-06 |
305 |
CHOLESTEROL HOMEOSTASIS |
8 |
59 |
6.223e-07 |
9.463e-06 |
306 |
ORGAN MORPHOGENESIS |
29 |
841 |
6.191e-07 |
9.463e-06 |
307 |
INSULIN RECEPTOR SIGNALING PATHWAY |
9 |
80 |
6.247e-07 |
9.468e-06 |
308 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
18 |
363 |
6.675e-07 |
1.008e-05 |
309 |
REGULATION OF CELL ACTIVATION |
21 |
484 |
6.889e-07 |
1.037e-05 |
310 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
9 |
81 |
6.953e-07 |
1.044e-05 |
311 |
LEARNING |
11 |
131 |
7.03e-07 |
1.052e-05 |
312 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
8 |
60 |
7.104e-07 |
1.06e-05 |
313 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
18 |
365 |
7.227e-07 |
1.074e-05 |
314 |
CIRCULATORY SYSTEM PROCESS |
18 |
366 |
7.518e-07 |
1.097e-05 |
315 |
NEUROTRANSMITTER UPTAKE |
5 |
15 |
7.489e-07 |
1.097e-05 |
316 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
7 |
42 |
7.512e-07 |
1.097e-05 |
317 |
REGULATION OF CELLULAR CARBOHYDRATE CATABOLIC PROCESS |
7 |
42 |
7.512e-07 |
1.097e-05 |
318 |
LONG CHAIN FATTY ACID TRANSPORT |
7 |
42 |
7.512e-07 |
1.097e-05 |
319 |
REGULATION OF CARBOHYDRATE CATABOLIC PROCESS |
7 |
42 |
7.512e-07 |
1.097e-05 |
320 |
FAT CELL DIFFERENTIATION |
10 |
106 |
7.761e-07 |
1.129e-05 |
321 |
REGENERATION |
12 |
161 |
7.904e-07 |
1.146e-05 |
322 |
REGULATION OF HOMEOSTATIC PROCESS |
20 |
447 |
7.968e-07 |
1.151e-05 |
323 |
REGULATION OF PROTEIN LOCALIZATION |
31 |
950 |
8.01e-07 |
1.154e-05 |
324 |
MEMBRANE DEPOLARIZATION |
8 |
61 |
8.09e-07 |
1.162e-05 |
325 |
REGULATION OF INTRACELLULAR TRANSPORT |
24 |
621 |
8.592e-07 |
1.23e-05 |
326 |
POSITIVE REGULATION OF SECRETION |
18 |
370 |
8.791e-07 |
1.251e-05 |
327 |
REGULATION OF BLOOD CIRCULATION |
16 |
295 |
8.795e-07 |
1.251e-05 |
328 |
RESPONSE TO COLD |
7 |
43 |
8.878e-07 |
1.259e-05 |
329 |
METAL ION TRANSPORT |
23 |
582 |
1.006e-06 |
1.419e-05 |
330 |
RHYTHMIC PROCESS |
16 |
298 |
1.005e-06 |
1.419e-05 |
331 |
BICARBONATE TRANSPORT |
7 |
44 |
1.045e-06 |
1.468e-05 |
332 |
CATABOLIC PROCESS |
46 |
1773 |
1.048e-06 |
1.468e-05 |
333 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
5 |
16 |
1.078e-06 |
1.507e-05 |
334 |
RESPONSE TO CARBOHYDRATE |
12 |
168 |
1.243e-06 |
1.731e-05 |
335 |
CARBOXYLIC ACID BIOSYNTHETIC PROCESS |
15 |
270 |
1.443e-06 |
1.998e-05 |
336 |
ORGANIC ACID BIOSYNTHETIC PROCESS |
15 |
270 |
1.443e-06 |
1.998e-05 |
337 |
ORGANONITROGEN COMPOUND METABOLIC PROCESS |
46 |
1796 |
1.494e-06 |
2.063e-05 |
338 |
POSITIVE REGULATION OF STEROL TRANSPORT |
5 |
17 |
1.512e-06 |
2.067e-05 |
339 |
POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS |
5 |
17 |
1.512e-06 |
2.067e-05 |
340 |
HEART DEVELOPMENT |
20 |
466 |
1.514e-06 |
2.067e-05 |
341 |
POSITIVE REGULATION OF CHOLESTEROL TRANSPORT |
5 |
17 |
1.512e-06 |
2.067e-05 |
342 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
13 |
203 |
1.534e-06 |
2.088e-05 |
343 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
6 |
30 |
1.547e-06 |
2.098e-05 |
344 |
REGULATION OF PH |
9 |
89 |
1.555e-06 |
2.103e-05 |
345 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
12 |
172 |
1.593e-06 |
2.149e-05 |
346 |
REPRODUCTION |
37 |
1297 |
1.621e-06 |
2.18e-05 |
347 |
CELLULAR RESPONSE TO ALCOHOL |
10 |
115 |
1.648e-06 |
2.21e-05 |
348 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
8 |
67 |
1.681e-06 |
2.239e-05 |
349 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
33 |
1087 |
1.684e-06 |
2.239e-05 |
350 |
EXOCYTOSIS |
16 |
310 |
1.684e-06 |
2.239e-05 |
351 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
9 |
90 |
1.709e-06 |
2.266e-05 |
352 |
REGULATION OF CELL DEVELOPMENT |
28 |
836 |
1.732e-06 |
2.29e-05 |
353 |
REGULATION OF JAK STAT CASCADE |
11 |
144 |
1.8e-06 |
2.339e-05 |
354 |
REGULATION OF PROTEIN SECRETION |
18 |
389 |
1.795e-06 |
2.339e-05 |
355 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
11 |
144 |
1.8e-06 |
2.339e-05 |
356 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
23 |
602 |
1.785e-06 |
2.339e-05 |
357 |
REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
11 |
144 |
1.8e-06 |
2.339e-05 |
358 |
REGULATION OF STAT CASCADE |
11 |
144 |
1.8e-06 |
2.339e-05 |
359 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
68 |
1.885e-06 |
2.443e-05 |
360 |
L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT |
6 |
31 |
1.898e-06 |
2.453e-05 |
361 |
NEGATIVE REGULATION OF MAPK CASCADE |
11 |
145 |
1.926e-06 |
2.483e-05 |
362 |
RESPONSE TO CAFFEINE |
5 |
18 |
2.073e-06 |
2.665e-05 |
363 |
RESPONSE TO ACTIVITY |
8 |
69 |
2.11e-06 |
2.705e-05 |
364 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
7 |
49 |
2.222e-06 |
2.833e-05 |
365 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
7 |
49 |
2.222e-06 |
2.833e-05 |
366 |
GLAND DEVELOPMENT |
18 |
395 |
2.228e-06 |
2.833e-05 |
367 |
GLYCEROLIPID BIOSYNTHETIC PROCESS |
13 |
211 |
2.36e-06 |
2.976e-05 |
368 |
RESPONSE TO TEMPERATURE STIMULUS |
11 |
148 |
2.355e-06 |
2.976e-05 |
369 |
LIPID OXIDATION |
8 |
70 |
2.357e-06 |
2.976e-05 |
370 |
CELLULAR RESPONSE TO CAMP |
7 |
50 |
2.557e-06 |
3.215e-05 |
371 |
MULTI MULTICELLULAR ORGANISM PROCESS |
13 |
213 |
2.62e-06 |
3.286e-05 |
372 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
29 |
905 |
2.678e-06 |
3.349e-05 |
373 |
NEGATIVE REGULATION OF GENE EXPRESSION |
40 |
1493 |
2.756e-06 |
3.438e-05 |
374 |
GAS TRANSPORT |
5 |
19 |
2.785e-06 |
3.456e-05 |
375 |
CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES |
5 |
19 |
2.785e-06 |
3.456e-05 |
376 |
NEURON PROJECTION REGENERATION |
6 |
33 |
2.797e-06 |
3.461e-05 |
377 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
15 |
285 |
2.815e-06 |
3.474e-05 |
378 |
POSITIVE REGULATION OF LIPID TRANSPORT |
7 |
51 |
2.933e-06 |
3.601e-05 |
379 |
CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS |
7 |
51 |
2.933e-06 |
3.601e-05 |
380 |
CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS |
9 |
96 |
2.943e-06 |
3.603e-05 |
381 |
CELLULAR RESPONSE TO KETONE |
8 |
73 |
3.251e-06 |
3.97e-05 |
382 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
7 |
52 |
3.354e-06 |
4.074e-05 |
383 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
26 |
767 |
3.354e-06 |
4.074e-05 |
384 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
18 |
408 |
3.506e-06 |
4.248e-05 |
385 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
10 |
125 |
3.522e-06 |
4.256e-05 |
386 |
GLYCOSYL COMPOUND METABOLIC PROCESS |
17 |
368 |
3.578e-06 |
4.313e-05 |
387 |
HYDROGEN PEROXIDE CATABOLIC PROCESS |
5 |
20 |
3.676e-06 |
4.42e-05 |
388 |
LIPID BIOSYNTHETIC PROCESS |
21 |
539 |
3.783e-06 |
4.537e-05 |
389 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
28 |
872 |
3.881e-06 |
4.642e-05 |
390 |
REGULATION OF HEART CONTRACTION |
13 |
221 |
3.932e-06 |
4.679e-05 |
391 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
11 |
156 |
3.931e-06 |
4.679e-05 |
392 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
6 |
35 |
4.015e-06 |
4.765e-05 |
393 |
REGULATION OF GLUCOSE TRANSPORT |
9 |
100 |
4.136e-06 |
4.897e-05 |
394 |
REGULATION OF NEUROTRANSMITTER LEVELS |
12 |
190 |
4.494e-06 |
5.307e-05 |
395 |
REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
6 |
36 |
4.768e-06 |
5.598e-05 |
396 |
REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS |
5 |
21 |
4.776e-06 |
5.598e-05 |
397 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
5 |
21 |
4.776e-06 |
5.598e-05 |
398 |
DETOXIFICATION |
8 |
77 |
4.877e-06 |
5.702e-05 |
399 |
CELL MOTILITY |
27 |
835 |
5.147e-06 |
5.987e-05 |
400 |
LOCALIZATION OF CELL |
27 |
835 |
5.147e-06 |
5.987e-05 |
401 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
6 |
37 |
5.632e-06 |
6.536e-05 |
402 |
RESPONSE TO IMMOBILIZATION STRESS |
5 |
22 |
6.119e-06 |
7.083e-05 |
403 |
HORMONE METABOLIC PROCESS |
11 |
164 |
6.363e-06 |
7.347e-05 |
404 |
REGULATION OF FAT CELL DIFFERENTIATION |
9 |
106 |
6.697e-06 |
7.713e-05 |
405 |
REGULATION OF TRANSPORTER ACTIVITY |
12 |
198 |
6.858e-06 |
7.879e-05 |
406 |
NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
4 |
11 |
6.999e-06 |
7.995e-05 |
407 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
19 |
472 |
7.01e-06 |
7.995e-05 |
408 |
RESPONSE TO TUMOR NECROSIS FACTOR |
13 |
233 |
6.992e-06 |
7.995e-05 |
409 |
L AMINO ACID TRANSPORT |
7 |
58 |
7.077e-06 |
8.032e-05 |
410 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
7 |
58 |
7.077e-06 |
8.032e-05 |
411 |
PHENOL CONTAINING COMPOUND METABOLIC PROCESS |
8 |
81 |
7.146e-06 |
8.07e-05 |
412 |
REGULATION OF EPITHELIAL CELL MIGRATION |
11 |
166 |
7.146e-06 |
8.07e-05 |
413 |
PLATELET DEGRANULATION |
9 |
107 |
7.234e-06 |
8.15e-05 |
414 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
12 |
200 |
7.597e-06 |
8.538e-05 |
415 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
6 |
39 |
7.743e-06 |
8.64e-05 |
416 |
LONG TERM SYNAPTIC POTENTIATION |
6 |
39 |
7.743e-06 |
8.64e-05 |
417 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
6 |
39 |
7.743e-06 |
8.64e-05 |
418 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
11 |
168 |
8.01e-06 |
8.917e-05 |
419 |
PROTEIN OLIGOMERIZATION |
18 |
434 |
8.205e-06 |
9.111e-05 |
420 |
HEAD DEVELOPMENT |
24 |
709 |
8.35e-06 |
9.251e-05 |
421 |
REGULATION OF ANION TRANSPORT |
10 |
138 |
8.534e-06 |
9.431e-05 |
422 |
REGULATION OF LIPASE ACTIVITY |
8 |
83 |
8.579e-06 |
9.437e-05 |
423 |
RESPONSE TO FATTY ACID |
8 |
83 |
8.579e-06 |
9.437e-05 |
424 |
REGULATION OF MONOOXYGENASE ACTIVITY |
7 |
60 |
8.902e-06 |
9.769e-05 |
425 |
DEFENSE RESPONSE |
34 |
1231 |
8.993e-06 |
9.846e-05 |
426 |
CELLULAR ALDEHYDE METABOLIC PROCESS |
8 |
84 |
9.382e-06 |
0.0001022 |
427 |
POSITIVE REGULATION OF OSSIFICATION |
8 |
84 |
9.382e-06 |
0.0001022 |
428 |
CARBOXYLIC ACID CATABOLIC PROCESS |
12 |
205 |
9.759e-06 |
0.0001058 |
429 |
ORGANIC ACID CATABOLIC PROCESS |
12 |
205 |
9.759e-06 |
0.0001058 |
430 |
REGULATION OF SEQUESTERING OF TRIGLYCERIDE |
4 |
12 |
1.04e-05 |
0.0001122 |
431 |
POSITIVE REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY |
4 |
12 |
1.04e-05 |
0.0001122 |
432 |
CELL PROLIFERATION |
23 |
672 |
1.089e-05 |
0.0001173 |
433 |
PLATELET ACTIVATION |
10 |
142 |
1.098e-05 |
0.000118 |
434 |
POSITIVE REGULATION OF NUCLEAR DIVISION |
7 |
62 |
1.11e-05 |
0.000119 |
435 |
OVULATION CYCLE |
9 |
113 |
1.13e-05 |
0.0001208 |
436 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
24 |
724 |
1.181e-05 |
0.0001257 |
437 |
HOMEOSTASIS OF NUMBER OF CELLS |
11 |
175 |
1.18e-05 |
0.0001257 |
438 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
9 |
114 |
1.213e-05 |
0.0001289 |
439 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
21 |
583 |
1.251e-05 |
0.0001326 |
440 |
MYELOID CELL HOMEOSTASIS |
8 |
88 |
1.326e-05 |
0.00014 |
441 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
14 |
285 |
1.327e-05 |
0.00014 |
442 |
REGULATION OF METAL ION TRANSPORT |
15 |
325 |
1.367e-05 |
0.0001439 |
443 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
7 |
64 |
1.373e-05 |
0.0001439 |
444 |
REGULATION OF PROTEIN ACETYLATION |
7 |
64 |
1.373e-05 |
0.0001439 |
445 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
6 |
43 |
1.388e-05 |
0.0001445 |
446 |
MYELOID LEUKOCYTE MEDIATED IMMUNITY |
6 |
43 |
1.388e-05 |
0.0001445 |
447 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
6 |
43 |
1.388e-05 |
0.0001445 |
448 |
FEMALE SEX DIFFERENTIATION |
9 |
116 |
1.397e-05 |
0.0001451 |
449 |
REGULATION OF AUTOPHAGY |
13 |
249 |
1.425e-05 |
0.0001476 |
450 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
12 |
213 |
1.434e-05 |
0.0001483 |
451 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
13 |
250 |
1.486e-05 |
0.0001528 |
452 |
WHITE FAT CELL DIFFERENTIATION |
4 |
13 |
1.487e-05 |
0.0001528 |
453 |
POSITIVE REGULATION OF GLUCONEOGENESIS |
4 |
13 |
1.487e-05 |
0.0001528 |
454 |
CELLULAR RESPONSE TO RETINOIC ACID |
7 |
65 |
1.523e-05 |
0.0001561 |
455 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
6 |
44 |
1.591e-05 |
0.0001627 |
456 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
30 |
1047 |
1.598e-05 |
0.000163 |
457 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
27 |
891 |
1.654e-05 |
0.0001684 |
458 |
LEUKOCYTE ACTIVATION |
17 |
414 |
1.671e-05 |
0.0001697 |
459 |
ACID SECRETION |
7 |
66 |
1.686e-05 |
0.0001705 |
460 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
7 |
66 |
1.686e-05 |
0.0001705 |
461 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
22 |
643 |
1.713e-05 |
0.0001729 |
462 |
CELLULAR AMINO ACID METABOLIC PROCESS |
15 |
332 |
1.755e-05 |
0.0001764 |
463 |
EMBRYO DEVELOPMENT |
27 |
894 |
1.755e-05 |
0.0001764 |
464 |
RESPONSE TO LITHIUM ION |
5 |
27 |
1.784e-05 |
0.0001785 |
465 |
FLUID TRANSPORT |
5 |
27 |
1.784e-05 |
0.0001785 |
466 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
9 |
120 |
1.836e-05 |
0.0001833 |
467 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
11 |
185 |
1.986e-05 |
0.0001979 |
468 |
REGULATION OF CELL JUNCTION ASSEMBLY |
7 |
68 |
2.055e-05 |
0.0002043 |
469 |
POSITIVE REGULATION OF CHOLESTEROL EFFLUX |
4 |
14 |
2.062e-05 |
0.0002046 |
470 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
10 |
153 |
2.107e-05 |
0.0002086 |
471 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
21 |
606 |
2.222e-05 |
0.0002195 |
472 |
CARBOHYDRATE TRANSPORT |
8 |
95 |
2.328e-05 |
0.0002295 |
473 |
NEUROTRANSMITTER TRANSPORT |
10 |
155 |
2.358e-05 |
0.0002319 |
474 |
REGULATION OF IMMUNE RESPONSE |
26 |
858 |
2.393e-05 |
0.0002349 |
475 |
MYELOID CELL DIFFERENTIATION |
11 |
189 |
2.422e-05 |
0.0002373 |
476 |
BONE DEVELOPMENT |
10 |
156 |
2.492e-05 |
0.0002436 |
477 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
18 |
472 |
2.524e-05 |
0.0002462 |
478 |
DICARBOXYLIC ACID TRANSPORT |
7 |
71 |
2.732e-05 |
0.0002659 |
479 |
CELLULAR RESPONSE TO NITRIC OXIDE |
4 |
15 |
2.784e-05 |
0.0002688 |
480 |
OXYGEN TRANSPORT |
4 |
15 |
2.784e-05 |
0.0002688 |
481 |
REGULATION OF NEUROTRANSMITTER UPTAKE |
4 |
15 |
2.784e-05 |
0.0002688 |
482 |
FRUCTOSE METABOLIC PROCESS |
4 |
15 |
2.784e-05 |
0.0002688 |
483 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
12 |
228 |
2.818e-05 |
0.0002714 |
484 |
REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY |
6 |
49 |
2.993e-05 |
0.0002878 |
485 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
5 |
30 |
3.055e-05 |
0.0002919 |
486 |
SODIUM ION HOMEOSTASIS |
5 |
30 |
3.055e-05 |
0.0002919 |
487 |
HYDROGEN PEROXIDE METABOLIC PROCESS |
5 |
30 |
3.055e-05 |
0.0002919 |
488 |
REGULATION OF CYTOPLASMIC TRANSPORT |
18 |
481 |
3.233e-05 |
0.0003083 |
489 |
NEURON DIFFERENTIATION |
26 |
874 |
3.271e-05 |
0.0003112 |
490 |
ERYTHROCYTE HOMEOSTASIS |
7 |
73 |
3.277e-05 |
0.0003112 |
491 |
STEROL TRANSPORT |
6 |
50 |
3.367e-05 |
0.0003191 |
492 |
HEMOSTASIS |
14 |
311 |
3.487e-05 |
0.0003298 |
493 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
7 |
74 |
3.582e-05 |
0.0003374 |
494 |
NEGATIVE REGULATION OF HORMONE SECRETION |
7 |
74 |
3.582e-05 |
0.0003374 |
495 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
5 |
31 |
3.606e-05 |
0.0003389 |
496 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
10 |
163 |
3.632e-05 |
0.0003408 |
497 |
REGULATION OF FATTY ACID BETA OXIDATION |
4 |
16 |
3.677e-05 |
0.0003442 |
498 |
CELL MATURATION |
9 |
131 |
3.691e-05 |
0.0003449 |
499 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
25 |
829 |
3.744e-05 |
0.0003491 |
500 |
POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION |
6 |
51 |
3.777e-05 |
0.0003507 |
501 |
RESPONSE TO NICOTINE |
6 |
51 |
3.777e-05 |
0.0003507 |
502 |
NEGATIVE REGULATION OF SECRETION |
11 |
200 |
4.075e-05 |
0.0003777 |
503 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
9 |
133 |
4.159e-05 |
0.000384 |
504 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
9 |
133 |
4.159e-05 |
0.000384 |
505 |
REGULATION OF GROWTH |
21 |
633 |
4.19e-05 |
0.0003861 |
506 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA |
5 |
32 |
4.231e-05 |
0.0003883 |
507 |
REGULATION OF LIPID CATABOLIC PROCESS |
6 |
52 |
4.225e-05 |
0.0003883 |
508 |
POSITIVE REGULATION OF GROWTH |
12 |
238 |
4.285e-05 |
0.0003925 |
509 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
6 |
53 |
4.716e-05 |
0.0004294 |
510 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
6 |
53 |
4.716e-05 |
0.0004294 |
511 |
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
6 |
53 |
4.716e-05 |
0.0004294 |
512 |
POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS |
4 |
17 |
4.761e-05 |
0.0004327 |
513 |
RESPONSE TO DEXAMETHASONE |
5 |
33 |
4.936e-05 |
0.0004477 |
514 |
LOCOMOTION |
30 |
1114 |
5.067e-05 |
0.0004587 |
515 |
NEURON PROJECTION DEVELOPMENT |
19 |
545 |
5.089e-05 |
0.0004597 |
516 |
MONOSACCHARIDE TRANSPORT |
6 |
54 |
5.251e-05 |
0.0004735 |
517 |
REGULATION OF BINDING |
13 |
283 |
5.403e-05 |
0.0004863 |
518 |
NEUROGENESIS |
35 |
1402 |
5.433e-05 |
0.000488 |
519 |
TISSUE HOMEOSTASIS |
10 |
171 |
5.455e-05 |
0.0004881 |
520 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
10 |
171 |
5.455e-05 |
0.0004881 |
521 |
SKELETAL SYSTEM DEVELOPMENT |
17 |
455 |
5.475e-05 |
0.000489 |
522 |
RESPONSE TO RETINOIC ACID |
8 |
107 |
5.498e-05 |
0.0004901 |
523 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
11 |
207 |
5.57e-05 |
0.0004955 |
524 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
34 |
5.729e-05 |
0.0005087 |
525 |
REGULATION OF ORGANELLE ORGANIZATION |
31 |
1178 |
5.785e-05 |
0.0005127 |
526 |
NAD METABOLIC PROCESS |
6 |
55 |
5.834e-05 |
0.0005161 |
527 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
7 |
80 |
5.939e-05 |
0.0005243 |
528 |
REGULATION OF MITOCHONDRIAL FISSION |
4 |
18 |
6.063e-05 |
0.0005343 |
529 |
REGULATION OF CALCIUM ION TRANSPORT |
11 |
209 |
6.075e-05 |
0.0005344 |
530 |
VESICLE MEDIATED TRANSPORT |
32 |
1239 |
6.21e-05 |
0.0005452 |
531 |
METANEPHROS DEVELOPMENT |
7 |
81 |
6.433e-05 |
0.0005626 |
532 |
REGULATION OF FIBROBLAST PROLIFERATION |
7 |
81 |
6.433e-05 |
0.0005626 |
533 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
6 |
56 |
6.467e-05 |
0.0005646 |
534 |
NADH METABOLIC PROCESS |
5 |
35 |
6.617e-05 |
0.0005744 |
535 |
REGULATION OF DIGESTIVE SYSTEM PROCESS |
5 |
35 |
6.617e-05 |
0.0005744 |
536 |
RESPONSE TO IRON ION |
5 |
35 |
6.617e-05 |
0.0005744 |
537 |
LEUKOCYTE DIFFERENTIATION |
13 |
292 |
7.426e-05 |
0.0006435 |
538 |
RESPONSE TO MUSCLE STRETCH |
4 |
19 |
7.605e-05 |
0.0006544 |
539 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
5 |
36 |
7.607e-05 |
0.0006544 |
540 |
CELLULAR SODIUM ION HOMEOSTASIS |
4 |
19 |
7.605e-05 |
0.0006544 |
541 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
8 |
112 |
7.608e-05 |
0.0006544 |
542 |
CELL CELL SIGNALING |
23 |
767 |
8.436e-05 |
0.0007242 |
543 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
13 |
296 |
8.518e-05 |
0.0007299 |
544 |
VASCULOGENESIS |
6 |
59 |
8.702e-05 |
0.0007435 |
545 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
5 |
37 |
8.708e-05 |
0.0007435 |
546 |
REGULATION OF DNA METABOLIC PROCESS |
14 |
340 |
9.09e-05 |
0.0007746 |
547 |
REGULATION OF CHOLESTEROL EFFLUX |
4 |
20 |
9.414e-05 |
0.0008008 |
548 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
10 |
183 |
9.621e-05 |
0.0008169 |
549 |
LEUKOCYTE MIGRATION |
12 |
259 |
9.638e-05 |
0.0008169 |
550 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
19 |
573 |
9.854e-05 |
0.0008336 |
551 |
REGULATION OF PROTEIN STABILITY |
11 |
221 |
0.0001001 |
0.0008454 |
552 |
TISSUE REMODELING |
7 |
87 |
0.0001015 |
0.0008559 |
553 |
REGULATION OF COAGULATION |
7 |
88 |
0.0001092 |
0.0009152 |
554 |
OVULATION CYCLE PROCESS |
7 |
88 |
0.0001092 |
0.0009152 |
555 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
7 |
88 |
0.0001092 |
0.0009152 |
556 |
CELLULAR LIPID CATABOLIC PROCESS |
9 |
151 |
0.0001113 |
0.0009304 |
557 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
12 |
263 |
0.0001114 |
0.0009304 |
558 |
REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
4 |
21 |
0.0001152 |
0.0009536 |
559 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
16 |
437 |
0.0001147 |
0.0009536 |
560 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
16 |
437 |
0.0001147 |
0.0009536 |
561 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
6 |
62 |
0.0001151 |
0.0009536 |
562 |
RESPONSE TO NITRIC OXIDE |
4 |
21 |
0.0001152 |
0.0009536 |
563 |
REGULATION OF PEPTIDASE ACTIVITY |
15 |
392 |
0.0001158 |
0.0009573 |
564 |
ALCOHOL METABOLIC PROCESS |
14 |
348 |
0.0001161 |
0.000958 |
565 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
36 |
1517 |
0.0001176 |
0.0009681 |
566 |
PURINE CONTAINING COMPOUND METABOLIC PROCESS |
15 |
394 |
0.0001225 |
0.001007 |
567 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
9 |
153 |
0.000123 |
0.00101 |
568 |
CYTOKINE PRODUCTION |
8 |
120 |
0.0001236 |
0.001012 |
569 |
SEX DIFFERENTIATION |
12 |
266 |
0.0001239 |
0.001013 |
570 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
21 |
684 |
0.0001251 |
0.001021 |
571 |
MESONEPHROS DEVELOPMENT |
7 |
90 |
0.0001258 |
0.001025 |
572 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
14 |
351 |
0.000127 |
0.001033 |
573 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
9 |
154 |
0.0001293 |
0.00105 |
574 |
NEURON DEVELOPMENT |
21 |
687 |
0.0001328 |
0.001077 |
575 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
11 |
229 |
0.000137 |
0.001107 |
576 |
ALPHA AMINO ACID METABOLIC PROCESS |
11 |
229 |
0.000137 |
0.001107 |
577 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
6 |
64 |
0.0001375 |
0.001109 |
578 |
IN UTERO EMBRYONIC DEVELOPMENT |
13 |
311 |
0.0001394 |
0.001117 |
579 |
NEGATIVE REGULATION OF HEART CONTRACTION |
4 |
22 |
0.0001394 |
0.001117 |
580 |
REGULATION OF RESPONSE TO INTERFERON GAMMA |
4 |
22 |
0.0001394 |
0.001117 |
581 |
HISTONE H3 DEACETYLATION |
4 |
22 |
0.0001394 |
0.001117 |
582 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
9 |
156 |
0.0001426 |
0.00114 |
583 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
5 |
41 |
0.0001438 |
0.001145 |
584 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
13 |
312 |
0.0001439 |
0.001145 |
585 |
ANION HOMEOSTASIS |
5 |
41 |
0.0001438 |
0.001145 |
586 |
FOREBRAIN DEVELOPMENT |
14 |
357 |
0.0001516 |
0.001203 |
587 |
REGULATION OF HEMOPOIESIS |
13 |
314 |
0.0001533 |
0.001215 |
588 |
CELLULAR AMINO ACID BIOSYNTHETIC PROCESS |
7 |
93 |
0.0001546 |
0.001221 |
589 |
REGULATION OF DNA BINDING |
7 |
93 |
0.0001546 |
0.001221 |
590 |
CONNECTIVE TISSUE DEVELOPMENT |
10 |
194 |
0.0001555 |
0.001226 |
591 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
11 |
233 |
0.0001595 |
0.001256 |
592 |
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS |
16 |
450 |
0.0001604 |
0.001261 |
593 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
5 |
42 |
0.0001616 |
0.001266 |
594 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
5 |
42 |
0.0001616 |
0.001266 |
595 |
REGULATION OF MUSCLE SYSTEM PROCESS |
10 |
195 |
0.0001622 |
0.001268 |
596 |
REGULATION OF CARDIAC CONDUCTION |
6 |
66 |
0.0001633 |
0.001275 |
597 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS |
4 |
23 |
0.0001671 |
0.001303 |
598 |
MUSCLE TISSUE DEVELOPMENT |
12 |
275 |
0.000169 |
0.001315 |
599 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
11 |
235 |
0.0001718 |
0.001335 |
600 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
8 |
126 |
0.0001733 |
0.001344 |
601 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
7 |
95 |
0.0001766 |
0.001367 |
602 |
POSITIVE REGULATION OF PROTEOLYSIS |
14 |
363 |
0.0001801 |
0.001392 |
603 |
REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY |
5 |
43 |
0.0001811 |
0.001397 |
604 |
NEGATIVE REGULATION OF ION TRANSPORT |
8 |
127 |
0.0001831 |
0.00141 |
605 |
STEROID METABOLIC PROCESS |
11 |
237 |
0.000185 |
0.001423 |
606 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
18 |
554 |
0.0001931 |
0.001481 |
607 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
12 |
279 |
0.0001931 |
0.001481 |
608 |
REGULATION OF MYELOID CELL APOPTOTIC PROCESS |
4 |
24 |
0.0001986 |
0.001515 |
609 |
AXON REGENERATION |
4 |
24 |
0.0001986 |
0.001515 |
610 |
AMMONIUM TRANSMEMBRANE TRANSPORT |
4 |
24 |
0.0001986 |
0.001515 |
611 |
NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
5 |
44 |
0.0002022 |
0.00154 |
612 |
CELLULAR CATABOLIC PROCESS |
32 |
1322 |
0.0002048 |
0.001557 |
613 |
REGULATION OF ION HOMEOSTASIS |
10 |
201 |
0.0002074 |
0.001574 |
614 |
ENDOCYTOSIS |
17 |
509 |
0.0002109 |
0.001598 |
615 |
REGULATION OF PROTEOLYSIS |
21 |
711 |
0.0002122 |
0.001606 |
616 |
MEMORY |
7 |
98 |
0.0002143 |
0.001616 |
617 |
MYELOID LEUKOCYTE ACTIVATION |
7 |
98 |
0.0002143 |
0.001616 |
618 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
16 |
462 |
0.0002159 |
0.001626 |
619 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
10 |
203 |
0.0002246 |
0.001689 |
620 |
REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS |
5 |
45 |
0.0002252 |
0.00169 |
621 |
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS |
4 |
25 |
0.0002342 |
0.001752 |
622 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
4 |
25 |
0.0002342 |
0.001752 |
623 |
POSITIVE REGULATION OF CELL DIVISION |
8 |
132 |
0.0002386 |
0.001782 |
624 |
MODIFICATION OF MORPHOLOGY OR PHYSIOLOGY OF OTHER ORGANISM |
7 |
100 |
0.0002429 |
0.001811 |
625 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
14 |
375 |
0.0002512 |
0.00187 |
626 |
DICARBOXYLIC ACID METABOLIC PROCESS |
7 |
101 |
0.0002583 |
0.00192 |
627 |
ENERGY RESERVE METABOLIC PROCESS |
6 |
72 |
0.000264 |
0.001959 |
628 |
REGULATION OF DEVELOPMENTAL GROWTH |
12 |
289 |
0.0002668 |
0.001973 |
629 |
APOPTOTIC SIGNALING PATHWAY |
12 |
289 |
0.0002668 |
0.001973 |
630 |
CHOLESTEROL EFFLUX |
4 |
26 |
0.0002741 |
0.002024 |
631 |
ADULT BEHAVIOR |
8 |
135 |
0.000278 |
0.00204 |
632 |
ADP METABOLIC PROCESS |
5 |
47 |
0.0002772 |
0.00204 |
633 |
REGULATION OF GTPASE ACTIVITY |
20 |
673 |
0.0002776 |
0.00204 |
634 |
PRIMARY ALCOHOL METABOLIC PROCESS |
5 |
47 |
0.0002772 |
0.00204 |
635 |
COFACTOR METABOLIC PROCESS |
13 |
334 |
0.0002796 |
0.002049 |
636 |
REGULATION OF PEPTIDE SECRETION |
10 |
209 |
0.0002837 |
0.002076 |
637 |
ASSOCIATIVE LEARNING |
6 |
73 |
0.0002847 |
0.00208 |
638 |
MEMBRANE HYPERPOLARIZATION |
3 |
11 |
0.0002854 |
0.002081 |
639 |
RESPONSE TO ETHANOL |
8 |
136 |
0.0002923 |
0.002128 |
640 |
OSSIFICATION |
11 |
251 |
0.0003031 |
0.002204 |
641 |
POSITIVE REGULATION OF PROTEIN SECRETION |
10 |
211 |
0.0003061 |
0.002222 |
642 |
CIRCADIAN RHYTHM |
8 |
137 |
0.0003072 |
0.002223 |
643 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
6 |
74 |
0.0003067 |
0.002223 |
644 |
LIPID STORAGE |
4 |
27 |
0.0003186 |
0.002299 |
645 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
4 |
27 |
0.0003186 |
0.002299 |
646 |
REGULATION OF CELL ADHESION |
19 |
629 |
0.0003224 |
0.00232 |
647 |
PLACENTA DEVELOPMENT |
8 |
138 |
0.0003227 |
0.00232 |
648 |
MUSCLE STRUCTURE DEVELOPMENT |
15 |
432 |
0.00033 |
0.00237 |
649 |
HEXOSE CATABOLIC PROCESS |
5 |
49 |
0.0003377 |
0.002418 |
650 |
GLOMERULUS DEVELOPMENT |
5 |
49 |
0.0003377 |
0.002418 |
651 |
REGULATION OF SYNAPTIC PLASTICITY |
8 |
140 |
0.0003555 |
0.002541 |
652 |
GLUTAMATE SECRETION |
4 |
28 |
0.0003682 |
0.002615 |
653 |
OXIDOREDUCTION COENZYME METABOLIC PROCESS |
7 |
107 |
0.0003678 |
0.002615 |
654 |
CELL VOLUME HOMEOSTASIS |
4 |
28 |
0.0003682 |
0.002615 |
655 |
REGULATION OF SPROUTING ANGIOGENESIS |
4 |
28 |
0.0003682 |
0.002615 |
656 |
LACTATE TRANSPORT |
3 |
12 |
0.000377 |
0.002626 |
657 |
REGULATION OF ORGANIC ACID TRANSPORT |
5 |
50 |
0.0003715 |
0.002626 |
658 |
SODIUM ION EXPORT |
3 |
12 |
0.000377 |
0.002626 |
659 |
RESPONSE TO PHENYLPROPANOID |
3 |
12 |
0.000377 |
0.002626 |
660 |
NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS |
17 |
535 |
0.0003752 |
0.002626 |
661 |
PROTEIN COMPLEX BIOGENESIS |
28 |
1132 |
0.0003718 |
0.002626 |
662 |
VESICLE FUSION TO PLASMA MEMBRANE |
3 |
12 |
0.000377 |
0.002626 |
663 |
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY |
3 |
12 |
0.000377 |
0.002626 |
664 |
BASIC AMINO ACID TRANSPORT |
3 |
12 |
0.000377 |
0.002626 |
665 |
LACTATE TRANSMEMBRANE TRANSPORT |
3 |
12 |
0.000377 |
0.002626 |
666 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
3 |
12 |
0.000377 |
0.002626 |
667 |
SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE |
3 |
12 |
0.000377 |
0.002626 |
668 |
PROTEIN COMPLEX ASSEMBLY |
28 |
1132 |
0.0003718 |
0.002626 |
669 |
IMMUNE EFFECTOR PROCESS |
16 |
486 |
0.0003786 |
0.002633 |
670 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
20 |
691 |
0.0003893 |
0.002704 |
671 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
9 |
179 |
0.0003969 |
0.002752 |
672 |
CELLULAR RESPIRATION |
8 |
143 |
0.00041 |
0.002839 |
673 |
RESPONSE TO ISCHEMIA |
4 |
29 |
0.0004229 |
0.002903 |
674 |
REGULATION OF THE FORCE OF HEART CONTRACTION |
4 |
29 |
0.0004229 |
0.002903 |
675 |
NEUTRAL LIPID BIOSYNTHETIC PROCESS |
4 |
29 |
0.0004229 |
0.002903 |
676 |
POTASSIUM ION IMPORT |
4 |
29 |
0.0004229 |
0.002903 |
677 |
GLUCOSE CATABOLIC PROCESS |
4 |
29 |
0.0004229 |
0.002903 |
678 |
ACYLGLYCEROL BIOSYNTHETIC PROCESS |
4 |
29 |
0.0004229 |
0.002903 |
679 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
8 |
144 |
0.0004295 |
0.002943 |
680 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
12 |
306 |
0.0004466 |
0.003047 |
681 |
INTERACTION WITH SYMBIONT |
5 |
52 |
0.0004467 |
0.003047 |
682 |
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
52 |
0.0004467 |
0.003047 |
683 |
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS |
6 |
80 |
0.0004678 |
0.003187 |
684 |
REGULATION OF VASCULOGENESIS |
3 |
13 |
0.0004856 |
0.003247 |
685 |
LEUKOCYTE DEGRANULATION |
4 |
30 |
0.0004833 |
0.003247 |
686 |
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN |
3 |
13 |
0.0004856 |
0.003247 |
687 |
LIPOPROTEIN TRANSPORT |
3 |
13 |
0.0004856 |
0.003247 |
688 |
POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
3 |
13 |
0.0004856 |
0.003247 |
689 |
DICARBOXYLIC ACID BIOSYNTHETIC PROCESS |
3 |
13 |
0.0004856 |
0.003247 |
690 |
CELLULAR AMINO ACID CATABOLIC PROCESS |
7 |
112 |
0.0004851 |
0.003247 |
691 |
REGULATION OF ACYL COA BIOSYNTHETIC PROCESS |
3 |
13 |
0.0004856 |
0.003247 |
692 |
TRANSEPITHELIAL TRANSPORT |
3 |
13 |
0.0004856 |
0.003247 |
693 |
BROWN FAT CELL DIFFERENTIATION |
4 |
30 |
0.0004833 |
0.003247 |
694 |
LIPOPROTEIN LOCALIZATION |
3 |
13 |
0.0004856 |
0.003247 |
695 |
COENZYME METABOLIC PROCESS |
11 |
265 |
0.0004794 |
0.003247 |
696 |
DIVALENT INORGANIC ANION HOMEOSTASIS |
3 |
13 |
0.0004856 |
0.003247 |
697 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
6 |
81 |
0.0005001 |
0.003339 |
698 |
POSITIVE REGULATION OF CELL ACTIVATION |
12 |
311 |
0.0005158 |
0.003439 |
699 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
30 |
1275 |
0.0005243 |
0.00349 |
700 |
REGULATION OF INNATE IMMUNE RESPONSE |
13 |
357 |
0.0005261 |
0.003497 |
701 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
15 |
452 |
0.0005291 |
0.003512 |
702 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
5 |
54 |
0.0005327 |
0.003531 |
703 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
17 |
552 |
0.0005346 |
0.003538 |
704 |
EMBRYONIC ORGAN DEVELOPMENT |
14 |
406 |
0.0005559 |
0.003674 |
705 |
REGULATION OF NEURON DIFFERENTIATION |
17 |
554 |
0.0005567 |
0.003674 |
706 |
RESPONSE TO INTERLEUKIN 1 |
7 |
115 |
0.0005687 |
0.003737 |
707 |
NEPHRON DEVELOPMENT |
7 |
115 |
0.0005687 |
0.003737 |
708 |
RESPONSE TO CALCIUM ION |
7 |
115 |
0.0005687 |
0.003737 |
709 |
MULTICELLULAR ORGANISM REPRODUCTION |
21 |
768 |
0.0005867 |
0.003851 |
710 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
34 |
1527 |
0.0005911 |
0.003874 |
711 |
PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION |
7 |
116 |
0.0005989 |
0.00392 |
712 |
POSITIVE REGULATION OF MITOCHONDRIAL FISSION |
3 |
14 |
0.0006125 |
0.003936 |
713 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
6 |
84 |
0.0006075 |
0.003936 |
714 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
3 |
14 |
0.0006125 |
0.003936 |
715 |
RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE |
3 |
14 |
0.0006125 |
0.003936 |
716 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
3 |
14 |
0.0006125 |
0.003936 |
717 |
CATECHOLAMINE TRANSPORT |
3 |
14 |
0.0006125 |
0.003936 |
718 |
STEM CELL DIFFERENTIATION |
9 |
190 |
0.0006114 |
0.003936 |
719 |
NEGATIVE REGULATION OF GLUCOSE IMPORT |
3 |
14 |
0.0006125 |
0.003936 |
720 |
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY |
3 |
14 |
0.0006125 |
0.003936 |
721 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
9 |
190 |
0.0006114 |
0.003936 |
722 |
RESPONSE TO LAMINAR FLUID SHEAR STRESS |
3 |
14 |
0.0006125 |
0.003936 |
723 |
REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS |
3 |
14 |
0.0006125 |
0.003936 |
724 |
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN |
3 |
14 |
0.0006125 |
0.003936 |
725 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
8 |
152 |
0.000615 |
0.003947 |
726 |
SINGLE ORGANISM CELL ADHESION |
15 |
459 |
0.0006196 |
0.00397 |
727 |
METANEPHRIC NEPHRON DEVELOPMENT |
4 |
32 |
0.000622 |
0.00397 |
728 |
BLOOD VESSEL REMODELING |
4 |
32 |
0.000622 |
0.00397 |
729 |
REGULATION OF ACTIN CYTOSKELETON REORGANIZATION |
4 |
32 |
0.000622 |
0.00397 |
730 |
RECEPTOR MEDIATED ENDOCYTOSIS |
10 |
231 |
0.0006232 |
0.003972 |
731 |
REGULATION OF CYTOKINE PRODUCTION |
17 |
563 |
0.0006663 |
0.004241 |
732 |
POTASSIUM ION TRANSPORT |
8 |
154 |
0.0006703 |
0.004261 |
733 |
POSITIVE REGULATION OF DNA REPLICATION |
6 |
86 |
0.0006884 |
0.00437 |
734 |
MUSCLE ORGAN DEVELOPMENT |
11 |
277 |
0.0006923 |
0.004387 |
735 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
16 |
514 |
0.000693 |
0.004387 |
736 |
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
4 |
33 |
0.000701 |
0.004432 |
737 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
8 |
156 |
0.0007294 |
0.004605 |
738 |
VITAMIN METABOLIC PROCESS |
7 |
120 |
0.000733 |
0.004622 |
739 |
POSITIVE REGULATION OF ION TRANSPORT |
10 |
236 |
0.000735 |
0.004628 |
740 |
ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB |
3 |
15 |
0.0007586 |
0.004713 |
741 |
INTERLEUKIN 1 PRODUCTION |
3 |
15 |
0.0007586 |
0.004713 |
742 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
3 |
15 |
0.0007586 |
0.004713 |
743 |
CELLULAR MONOVALENT INORGANIC ANION HOMEOSTASIS |
3 |
15 |
0.0007586 |
0.004713 |
744 |
LONG TERM SYNAPTIC DEPRESSION |
3 |
15 |
0.0007586 |
0.004713 |
745 |
CELLULAR ANION HOMEOSTASIS |
3 |
15 |
0.0007586 |
0.004713 |
746 |
RESPONSE TO VITAMIN E |
3 |
15 |
0.0007586 |
0.004713 |
747 |
REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS |
3 |
15 |
0.0007586 |
0.004713 |
748 |
RESPONSE TO HYDROPEROXIDE |
3 |
15 |
0.0007586 |
0.004713 |
749 |
RESPONSE TO MERCURY ION |
3 |
15 |
0.0007586 |
0.004713 |
750 |
WATER SOLUBLE VITAMIN METABOLIC PROCESS |
6 |
88 |
0.0007774 |
0.004823 |
751 |
REGULATION OF TRIGLYCERIDE METABOLIC PROCESS |
4 |
34 |
0.0007869 |
0.004869 |
752 |
RENAL WATER HOMEOSTASIS |
4 |
34 |
0.0007869 |
0.004869 |
753 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
9 |
197 |
0.0007916 |
0.004892 |
754 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
5 |
59 |
0.0008022 |
0.004931 |
755 |
MONOSACCHARIDE CATABOLIC PROCESS |
5 |
59 |
0.0008022 |
0.004931 |
756 |
MUSCLE SYSTEM PROCESS |
11 |
282 |
0.0008018 |
0.004931 |
757 |
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS |
5 |
59 |
0.0008022 |
0.004931 |
758 |
POSITIVE REGULATION OF CELL ADHESION |
13 |
376 |
0.00085 |
0.005213 |
759 |
REGULATION OF ENDOCYTOSIS |
9 |
199 |
0.0008504 |
0.005213 |
760 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
60 |
0.0008665 |
0.005305 |
761 |
SODIUM ION TRANSMEMBRANE TRANSPORT |
6 |
90 |
0.0008751 |
0.005344 |
762 |
REGULATION OF CELL MATRIX ADHESION |
6 |
90 |
0.0008751 |
0.005344 |
763 |
REGULATION OF GASTRULATION |
4 |
35 |
0.0008799 |
0.005345 |
764 |
NEURON APOPTOTIC PROCESS |
4 |
35 |
0.0008799 |
0.005345 |
765 |
REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS |
4 |
35 |
0.0008799 |
0.005345 |
766 |
RESPONSE TO MONOAMINE |
4 |
35 |
0.0008799 |
0.005345 |
767 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
14 |
426 |
0.0008866 |
0.005379 |
768 |
CARDIAC MYOFIBRIL ASSEMBLY |
3 |
16 |
0.0009252 |
0.005562 |
769 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
3 |
16 |
0.0009252 |
0.005562 |
770 |
POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION |
3 |
16 |
0.0009252 |
0.005562 |
771 |
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT |
3 |
16 |
0.0009252 |
0.005562 |
772 |
RESPONSE TO EPINEPHRINE |
3 |
16 |
0.0009252 |
0.005562 |
773 |
MONOCYTE DIFFERENTIATION |
3 |
16 |
0.0009252 |
0.005562 |
774 |
GLYCOSIDE METABOLIC PROCESS |
3 |
16 |
0.0009252 |
0.005562 |
775 |
DNA TEMPLATED TRANSCRIPTION INITIATION |
9 |
202 |
0.0009451 |
0.005674 |
776 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
13 |
381 |
0.0009587 |
0.005749 |
777 |
POSITIVE REGULATION OF HEMOPOIESIS |
8 |
163 |
0.0009706 |
0.005812 |
778 |
REGULATION OF WOUND HEALING |
7 |
126 |
0.0009776 |
0.005846 |
779 |
NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING |
4 |
36 |
0.0009803 |
0.005848 |
780 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
4 |
36 |
0.0009803 |
0.005848 |
781 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
6 |
92 |
0.000982 |
0.00585 |
782 |
CELL SUBSTRATE ADHESION |
8 |
164 |
0.00101 |
0.006008 |
783 |
POSITIVE REGULATION OF BINDING |
7 |
127 |
0.001024 |
0.006085 |
784 |
LIPID CATABOLIC PROCESS |
10 |
247 |
0.00104 |
0.006171 |
785 |
INORGANIC ANION TRANSPORT |
7 |
128 |
0.001072 |
0.006338 |
786 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
7 |
128 |
0.001072 |
0.006338 |
787 |
PROTEIN HOMOOLIGOMERIZATION |
10 |
248 |
0.001072 |
0.006338 |
788 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
20 |
750 |
0.001074 |
0.006339 |
789 |
REGULATION OF MUSCLE ADAPTATION |
5 |
63 |
0.001082 |
0.006374 |
790 |
RESPONSE TO OSMOTIC STRESS |
5 |
63 |
0.001082 |
0.006374 |
791 |
GLYCEROLIPID CATABOLIC PROCESS |
4 |
37 |
0.001089 |
0.006404 |
792 |
ELECTRON TRANSPORT CHAIN |
6 |
94 |
0.001099 |
0.006454 |
793 |
CELLULAR RESPONSE TO LITHIUM ION |
3 |
17 |
0.001113 |
0.006475 |
794 |
HEXOSE TRANSMEMBRANE TRANSPORT |
3 |
17 |
0.001113 |
0.006475 |
795 |
REGULATION OF ENERGY HOMEOSTASIS |
3 |
17 |
0.001113 |
0.006475 |
796 |
NEGATIVE REGULATION OF ANOIKIS |
3 |
17 |
0.001113 |
0.006475 |
797 |
GLUCOSE TRANSMEMBRANE TRANSPORT |
3 |
17 |
0.001113 |
0.006475 |
798 |
NEGATIVE REGULATION OF GLUCOSE TRANSPORT |
3 |
17 |
0.001113 |
0.006475 |
799 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
3 |
17 |
0.001113 |
0.006475 |
800 |
ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN |
3 |
17 |
0.001113 |
0.006475 |
801 |
ALPHA AMINO ACID CATABOLIC PROCESS |
6 |
95 |
0.001161 |
0.006743 |
802 |
RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS |
5 |
64 |
0.001162 |
0.006743 |
803 |
IMMUNE RESPONSE |
26 |
1100 |
0.001172 |
0.00679 |
804 |
LYMPHOCYTE ACTIVATION |
12 |
342 |
0.001178 |
0.006817 |
805 |
NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE |
4 |
38 |
0.001205 |
0.006956 |
806 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
4 |
38 |
0.001205 |
0.006956 |
807 |
ORGANONITROGEN COMPOUND CATABOLIC PROCESS |
12 |
343 |
0.001208 |
0.006962 |
808 |
MYELOID LEUKOCYTE DIFFERENTIATION |
6 |
96 |
0.001226 |
0.007039 |
809 |
PROTEIN STABILIZATION |
7 |
131 |
0.001227 |
0.007039 |
810 |
FEMALE GAMETE GENERATION |
6 |
96 |
0.001226 |
0.007039 |
811 |
MONOCARBOXYLIC ACID CATABOLIC PROCESS |
6 |
96 |
0.001226 |
0.007039 |
812 |
GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS |
5 |
65 |
0.001247 |
0.007117 |
813 |
REGULATION OF CHEMOKINE PRODUCTION |
5 |
65 |
0.001247 |
0.007117 |
814 |
REGULATION OF RESPONSE TO OXIDATIVE STRESS |
5 |
65 |
0.001247 |
0.007117 |
815 |
PYRUVATE METABOLIC PROCESS |
5 |
65 |
0.001247 |
0.007117 |
816 |
GLAND MORPHOGENESIS |
6 |
97 |
0.001293 |
0.007374 |
817 |
REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS |
8 |
171 |
0.00132 |
0.007437 |
818 |
CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS |
3 |
18 |
0.001324 |
0.007437 |
819 |
ATP GENERATION FROM ADP |
4 |
39 |
0.00133 |
0.007437 |
820 |
NEGATIVE REGULATION OF ENDOCYTOSIS |
4 |
39 |
0.00133 |
0.007437 |
821 |
POTASSIUM ION HOMEOSTASIS |
3 |
18 |
0.001324 |
0.007437 |
822 |
MODULATION BY HOST OF VIRAL PROCESS |
3 |
18 |
0.001324 |
0.007437 |
823 |
ORGAN MATURATION |
3 |
18 |
0.001324 |
0.007437 |
824 |
ANATOMICAL STRUCTURE MATURATION |
4 |
39 |
0.00133 |
0.007437 |
825 |
POLYOL TRANSPORT |
3 |
18 |
0.001324 |
0.007437 |
826 |
OVULATION |
3 |
18 |
0.001324 |
0.007437 |
827 |
REGULATION OF RESPONSE TO NUTRIENT LEVELS |
8 |
171 |
0.00132 |
0.007437 |
828 |
MAST CELL MEDIATED IMMUNITY |
3 |
18 |
0.001324 |
0.007437 |
829 |
EPITHELIAL CELL DIFFERENTIATION |
15 |
495 |
0.001322 |
0.007437 |
830 |
PLATELET AGGREGATION |
4 |
39 |
0.00133 |
0.007437 |
831 |
SPLEEN DEVELOPMENT |
4 |
39 |
0.00133 |
0.007437 |
832 |
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION |
4 |
39 |
0.00133 |
0.007437 |
833 |
REGULATION OF VASOCONSTRICTION |
5 |
66 |
0.001335 |
0.007459 |
834 |
REGULATION OF PEPTIDE TRANSPORT |
10 |
256 |
0.00136 |
0.007588 |
835 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
6 |
98 |
0.001363 |
0.007589 |
836 |
RESPONSE TO VITAMIN |
6 |
98 |
0.001363 |
0.007589 |
837 |
REGULATION OF CELL SIZE |
8 |
172 |
0.00137 |
0.007617 |
838 |
SIGNAL RELEASE |
8 |
173 |
0.001422 |
0.007893 |
839 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
11 |
303 |
0.00143 |
0.007931 |
840 |
CHLORIDE TRANSPORT |
6 |
99 |
0.001437 |
0.007958 |
841 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
4 |
40 |
0.001463 |
0.008097 |
842 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
9 |
216 |
0.001507 |
0.00833 |
843 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
6 |
100 |
0.001513 |
0.008351 |
844 |
REGULATION OF CYTOSKELETON ORGANIZATION |
15 |
502 |
0.001518 |
0.008366 |
845 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
7 |
136 |
0.001523 |
0.008388 |
846 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
3 |
19 |
0.001558 |
0.008477 |
847 |
KIDNEY VASCULATURE DEVELOPMENT |
3 |
19 |
0.001558 |
0.008477 |
848 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
3 |
19 |
0.001558 |
0.008477 |
849 |
REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
3 |
19 |
0.001558 |
0.008477 |
850 |
POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY |
3 |
19 |
0.001558 |
0.008477 |
851 |
REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
3 |
19 |
0.001558 |
0.008477 |
852 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
3 |
19 |
0.001558 |
0.008477 |
853 |
MONOVALENT INORGANIC ANION HOMEOSTASIS |
3 |
19 |
0.001558 |
0.008477 |
854 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
3 |
19 |
0.001558 |
0.008477 |
855 |
MACROPHAGE DIFFERENTIATION |
3 |
19 |
0.001558 |
0.008477 |
856 |
REGULATION OF PROTEIN TARGETING |
11 |
307 |
0.001587 |
0.008625 |
857 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
6 |
101 |
0.001592 |
0.008645 |
858 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
4 |
41 |
0.001606 |
0.00868 |
859 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
4 |
41 |
0.001606 |
0.00868 |
860 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
4 |
41 |
0.001606 |
0.00868 |
861 |
MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
4 |
41 |
0.001606 |
0.00868 |
862 |
NEGATIVE REGULATION OF OSSIFICATION |
5 |
69 |
0.00163 |
0.008788 |
863 |
IRON ION HOMEOSTASIS |
5 |
69 |
0.00163 |
0.008788 |
864 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
13 |
406 |
0.001693 |
0.00912 |
865 |
CATECHOLAMINE METABOLIC PROCESS |
4 |
42 |
0.001758 |
0.009424 |
866 |
POSITIVE REGULATION OF DNA BINDING |
4 |
42 |
0.001758 |
0.009424 |
867 |
REGULATION OF CIRCADIAN RHYTHM |
6 |
103 |
0.00176 |
0.009424 |
868 |
DETECTION OF MECHANICAL STIMULUS |
4 |
42 |
0.001758 |
0.009424 |
869 |
CATECHOL CONTAINING COMPOUND METABOLIC PROCESS |
4 |
42 |
0.001758 |
0.009424 |
870 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
13 |
408 |
0.001768 |
0.009457 |
871 |
EMBRYONIC HEMOPOIESIS |
3 |
20 |
0.001816 |
0.009559 |
872 |
GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS |
3 |
20 |
0.001816 |
0.009559 |
873 |
WATER TRANSPORT |
3 |
20 |
0.001816 |
0.009559 |
874 |
ALDITOL METABOLIC PROCESS |
3 |
20 |
0.001816 |
0.009559 |
875 |
MIDDLE EAR MORPHOGENESIS |
3 |
20 |
0.001816 |
0.009559 |
876 |
PROTEIN ADP RIBOSYLATION |
3 |
20 |
0.001816 |
0.009559 |
877 |
RESPONSE TO VITAMIN A |
3 |
20 |
0.001816 |
0.009559 |
878 |
REGULATION OF NEURON PROJECTION REGENERATION |
3 |
20 |
0.001816 |
0.009559 |
879 |
RESPONSE TO LIPOPROTEIN PARTICLE |
3 |
20 |
0.001816 |
0.009559 |
880 |
INTRACELLULAR LIPID TRANSPORT |
3 |
20 |
0.001816 |
0.009559 |
881 |
POSITIVE REGULATION OF LIPID STORAGE |
3 |
20 |
0.001816 |
0.009559 |
882 |
REGULATION OF SULFUR METABOLIC PROCESS |
3 |
20 |
0.001816 |
0.009559 |
883 |
MELANOCYTE DIFFERENTIATION |
3 |
20 |
0.001816 |
0.009559 |
884 |
RESPONSE TO LEPTIN |
3 |
20 |
0.001816 |
0.009559 |
885 |
INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
5 |
71 |
0.001851 |
0.009699 |
886 |
CELLULAR HORMONE METABOLIC PROCESS |
6 |
104 |
0.001849 |
0.009699 |
887 |
GROWTH |
13 |
410 |
0.001846 |
0.009699 |
888 |
BODY FLUID SECRETION |
5 |
71 |
0.001851 |
0.009699 |
889 |
INNATE IMMUNE RESPONSE |
17 |
619 |
0.001854 |
0.009703 |
890 |
CELL PROJECTION ORGANIZATION |
22 |
902 |
0.001905 |
0.009962 |